1International Agency for Research on Cancer (2004) Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide, [Ferlay, J, Bray, F, Pisani, P and Parkin, DM, editors]. Lyon, France: IARC Press.
2Yang, L, Parkin, DM, Ferlay, J, Li, L & Chen, Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14, 243–250.
3Sporn, MB & Suh, N (2002) Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2, 537–543.
4Shukla, S & Gupta, S (2005) Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53, 18–32.
5Packer, L & Landvik, S (1989) Vitamin E: introduction to biochemistry and health benefits. Ann N Y Acad Sci 570, 1–6.
6Weber, C, Podda, M, Rallis, M, Thiele, JJ, Traber, MG & Packer, L (1997) Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation. Free Radic Biol Med 22, 761–769.
7He, L, Mo, H, Hadisusilo, S, Qureshi, AA & Elson, CE (1997) Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 127, 668–674.
8Nesaretnam, K, Guthrie, N, Chambers, AF & Carroll, KK (1995) Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30, 1139–1143.
9Qureshi, AA, Sami, SA, Salser, WA & Khan, FA (2002) Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161, 199–207.
10Khanna, S, Roy, S, Ryu, H, Bahadduri, P, Swaan, PW, Ratan, RR & Sen, CK (2003) Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 278, 43508–43515.
11Nesaretnam, K, Ambra, R, Selvaduray, KR, Radhakrishnan, A, Canali, R & Virgili, F (2004) Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann N Y Acad Sci 1031, 143–157.
12Noguchi, N, Hanyu, R, Nonaka, A, Okimoto, Y & Kodama, T (2003) Inhibition of THP-1 cell adhesion to endothelial cells by α-tocopherol and α-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 34, 1614–1620.
13Naito, Y, Shimozawa, M, Kuroda, M, et al. (2005) Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180, 19–25.
14McIntyre, BS, Briski, KP, Gapor, A & Sylvester, PW (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224, 292–301.
15Gysin, R, Azzi, A & Visarius, T (2002) γ-Tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J 16, 1952–1954.
16Shah, S, Gapor, A & Sylvester, PW (2003) Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer 45, 236–246.
17Shun, MC, Yu, W, Gapor, A, Parsons, R, Atkinson, J, Sanders, BG & Kline, K (2004) Pro-apoptotic mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of vitamin E (δ-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 48, 95–105.
18Shah, SJ & Sylvester, PW (2005) γ-Tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor κB activity. Exp Biol Med (Maywood) 230, 235–241.
19Agarwal, MK, Agarwal, ML, Athar, M & Gupta, S (2004) Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3, 205–211.
20Janmejai, KS & Sanjay, G (2006) Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Comm 346, 447–453.
21Sakai, M, Okabe, M, Tachibana, H & Yamada, K (2006) Apoptosis induction by γ-tocotrienol in human hepatoma Hep3B cells. J Nutr Biochem 17, 672–676.
22Salvesen, GS & Dixit, VM (1997) Caspases: intracellular signaling by proteolysis. Cell 91, 443–446.
23Seger, R & Krebs, EG (1995) The MAPK signaling cascade. FASEB J 9, 726–735.
24Liang, B, Wang, S, Zhu, XG, Yu, YX, Cui, ZR & Yu, YZ (2005) Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J Gastroenterol 11, 623–628.
25Kasid, U & Dritschilo, A (2003) RAF antisense oligonucleotide as a tumor radiosensitizer. Oncogene 22, 5876–5884.
26Marampon, F, Ciccarelli, C & Zani, BM (2006) Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Mol Cancer 5, 31–48.
27Block, G, Patterson, B & Subar, A (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18, 1–29.
28Shao, ZM, Wu, J, Shen, ZZ & Barsky, SH (1998) Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58, 4851–4857.
29Zhou, JR, Mukherjee, P, Gugger, ET, Tanaka, T, Blackburn, GL & Clinton, SK (1998) Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 58, 5231–5238.
30Yap, SP, Yuen, KH & Wong, JW (2001) Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under different food status. J Pharm Pharmacol 53, 67–71.
31Sylvester, PW, Shah, SJ & Samant, GV (2005) Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of γ-tocotrienol in neoplastic mammary epithelial cells. J Plant Physiol 162, 803–810.
32Tsujimoto, Y & Shimizu, S (2000) Bcl-2 family: life-or-death switch. FEBS Lett 466, 6–10.
33Shimizu, S, Narita, M & Tsujimoto, Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483–487.
34Sylvester, PW, Nachnani, A, Shah, S & Briski, KP (2002) Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac J Clin Nutr 11, Suppl. 7, S452–S459.
35Wada, T & Penninger, JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23, 2838–2849.
36Gysin, S, Lee, SH, Dean, NM & McMahon, M (2005) Pharmacologic inhibition of RAF-MEK-ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. Cancer Res 65, 4870–4880.
37Klein, PJ, Schmidt, CM, Wiesenauer, CA, et al. (2006) The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer. Neoplasia 8, 1–8.
38Chen, BQ, Xue, YB, Liu, JR, Yang, YM, Zheng, YM, Wang, XL & Liu, RH (2003) Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo(a)pyrene and chemopreventive mechanisms. World J Gastroenterol 9, 44–49.
39Liu, JR, Yang, BF, Chen, BQ, Yang, YM, Dong, HW & Song, YQ (2004) Inhibition of β-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinases-1 and -2 expression. World J Gastroenterol 10, 167–171.
40Liu, JR, Chen, BQ, Yang, BF, Dong, HW, Sun, CH, Wang, Q, Guo, S & Song, YQ (2004) Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World J Gastroenterol 10, 348–351.
41Bocca, C, Bozzo, F, Gabriel, L & Miglietta, A (2007) Conjugated linoleic acid inhibits Caco-2 cell growth via ERK-MAPK signaling pathway. J Nutr Biochem 18, 332–340.
42Davis, RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252.
43Chang, L & Karin, M (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37–40.
44Johnson, GL & Lapadat, R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911–1912.
45Sarkar, D, Su, ZZ, Lebedeva, S IV, auane, M, Gopalkrishnan, RV, Valerie, K, Dent, P & Fisher, PB (2002) mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci U S A 99, 10054–10059.
46Porras, A, Zuluaga, S, Black, E, Valladares, A, Alvarez, AM, Ambrosino, C, Benito, M & Nebreda, AR (2004) p38 α Mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15, 922–933.
47Park, JM, Greten, FR, Li, ZW & Karin, M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297, 2048–2051.
48Juretic, N, Santibanez, JF, Hurtado, C & Martinez, J (2001) ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. J Cell Biochem 83, 92–98.
49Yosimichi, G, Nakanishi, T, Nishida, T, Hattori, T, TakanoYamamoto, T & Takigawa, M (2001) CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268, 6058–6065.